Selective potentiation of host resistance in mice following treatment with Pyrexol.
The purpose of this study was to examine the effect of treatment with the biologic response modifier Pyrexol on murine host resistance to various infectious organisms. Adult female CD1 mice were treated with a single subcutaneous 100-micrograms injection of Pyrexol at 14, 7, 5, 2, or 1 day prior to infection with various infectious organisms. These organisms included the Herpes simplex type 2 and influenza viruses, as well as the bacteria Listeria monocytogenes and Streptococcus zooepidemicus. Pyrexol treatment was found to significantly potentiate resistance to Listeria organisms, but had no appreciable effect on resistance to any of the other organisms tested. Previous reports have demonstrated that treatment with Pyrexol augments a number of cell-mediated immune parameters, several of which have been shown to be responsible for the elimination of Listeria organisms. These results suggest that Pyrexol is capable of selectively potentiating host resistance to infection.
House
R V
RV
Life Sciences Research, IIT Research Institute, Chicago, Illinois 60616.
Pearson
F C
FC
Thomas
P T
PT
D000818:Animals; D001688:Biological Products; D005260:Female; D006561:Herpes Simplex / Q000276:immunology / Q000517:prevention & control; D007109:Immunity / Q000187:drug effects*; D007111:Immunity, Cellular; D007155:Immunologic Factors / Q000627:therapeutic use*; D017053:Infection Control; D007239:Infections / Q000276:immunology; D008088:Listeriosis / Q000276:immunology / Q000517:prevention & control; D051379:Mice; D009976:Orthomyxoviridae Infections / Q000276:immunology / Q000517:prevention & control; D013290:Streptococcal Infections / Q000276:immunology / Q000517:prevention & control
D001688:Biological Products; D007155:Immunologic Factors; C062792:ImuVert